Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 39 articles: HTML format

Single Articles

June 2022
1. TOMII D, Pilgrim T, Heg D, Reineke D, et al
   Reply: Correlation of aortic root dimensions in patients undergoing transcatheter aortic valve implantation.
   Am Heart J. 2022;248:166-168.
   PubMed    
   
   
   
2. GUPTA K, Lee JC
   Assessment of sinus of valsalva dimensions before TAVI: An independent predictor of worse outcomes?
   Am Heart J. 2022;248:165.
   PubMed    
   
   
   February 2022
3. LINDER M, Higgen FL, Voigtlander L, Weimann J, et al
   Stroke events after transcatheter aortic valve implantation: Temporal relationships and affected brain regions.
   Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00030.
   PubMed     Abstract available
   
   
   January 2022
4. HERRMANN HC, Abdel-Wahab M, Attizzani GF, Batchelor W, et al
   Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial).
   Am Heart J. 2022;243:92-102.
   PubMed     Abstract available
   
   
   
5. BUTALA NM, Song Y, Shen C, Cohen DJ, et al
   Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial.
   Am Heart J. 2022;243:77-86.
   PubMed     Abstract available
   
   
   December 2021
6. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
   Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
   Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
   PubMed     Abstract available
   
   
   November 2021
7. I D, Okuno T, Heg D, Grani C, et al
   Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.
   Am Heart J. 2021 Nov 14. pii: S0002-8703(21)00447.
   PubMed     Abstract available
   
   
   September 2021
8. STRANGE JE, Sindet-Pedersen C, Gislason GH, Torp-Pedersen C, et al
   Title: Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study.
   Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00239.
   PubMed     Abstract available
   
   
   
9. CLARK KA, Chouairi F, Kay B, Reinhardt SW, et al
   Trends in Transcatheter and Surgical Aortic Valve Replacement in the United States, 2008-2018.
   Am Heart J. 2021 Sep 24. pii: S0002-8703(21)00232.
   PubMed     Abstract available
   
   
   
10. DESAI MY, Wolski K, Owens A, Naidu SS, et al
    Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy.
    Am Heart J. 2021;239:80-89.
    PubMed     Abstract available
    
    
    June 2021
11. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    PubMed     Abstract available
    
    
    April 2021
12. MARTIN AC, Hausleiter J, Karam N
    Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures.
    Am Heart J. 2021;234:136-137.
    PubMed    
    
    
    March 2021
13. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    PubMed     Abstract available
    
    
    
14. LOWENSTERN A, Sheridan P, Wang TY, Boero I, et al
    Sex Disparities in Patients with Symptomatic Severe Aortic Stenosis.
    Am Heart J. 2021 Mar 12. pii: S0002-8703(21)00074.
    PubMed     Abstract available
    
    
    
15. WAKSMAN R, Torguson R, Medranda GA, Shea C, et al
    Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial.
    Am Heart J. 2021 Mar 10. pii: S0002-8703(21)00071.
    PubMed     Abstract available
    
    
    January 2021
16. ADACHI Y, Yamamoto M, Shimura T, Yamaguchi R, et al
    Late kidney injury after transcatheter aortic valve replacement.
    Am Heart J. 2021 Jan 14. pii: S0002-8703(21)00011.
    PubMed     Abstract available
    
    
    
17. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available
    
    
    December 2020
18. MENTIAS A, Sarrazin MV, Desai M, Kapadia S, et al
    Expansion of Transcatheter Aortic Valve Replacement in the United States: Expansion of TAVR in US.
    Am Heart J. 2020 Dec 31. pii: S0002-8703(20)30427.
    PubMed     Abstract available
    
    
    November 2020
19. KAWASHIMA H, Soliman O, Wang R, Ono M, et al
    Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.
    Am Heart J. 2020 Nov 5. pii: S0002-8703(20)30368.
    PubMed     Abstract available
    
    
    
20. LACHTRUPP CL, Valente AM, Gurvitz M, Landzberg MJ, et al
    Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease.
    Am Heart J. 2020;229:92-99.
    PubMed     Abstract available
    
    
    October 2020
21. NATHAN AS, Yang L, Geng Z, Dayoub EJ, et al
    Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.
    Am Heart J. 2020;232:1-9.
    PubMed     Abstract available
    
    
    
22. GUIMARAES HP, de Barros E Silva PGM, Liporace IL, Sampaio RO, et al
    A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
    Am Heart J. 2020 Oct 9. pii: S0002-8703(20)30277.
    PubMed     Abstract available
    
    
    August 2020
23. AZEVEDO O, Marques N, Reis L, Cruz I, et al
    Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?
    Am Heart J. 2020;226:114-126.
    PubMed     Abstract available
    
    
    July 2020
24. BHARDWAJ B, Cohen DJ, Vemulapalli S, Kosinski AS, et al
    Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry.
    Am Heart J. 2020;228:57-64.
    PubMed     Abstract available
    
    
    
25. HERKERT JC, Verhagen JMA, Yotti R, Haghighi A, et al
    Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
    Am Heart J. 2020;225:108-119.
    PubMed     Abstract available
    
    
    June 2020
26. ELTCHANINOFF H, Bonaros N, Prendergast B, Nietlispach F, et al
    Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve interventio
    Am Heart J. 2020;228:27-35.
    PubMed     Abstract available
    
    
    
27. HOLMES DR JR, Mack MJ, Alkhouli M, Vemulapalli S, et al
    Racial disparities and democratization of health care: A focus on TAVR in the United States.
    Am Heart J. 2020;224:166-170.
    PubMed    
    
    
    April 2020
28. LUDWIG S, Gossling A, Waldschmidt L, Linder M, et al
    TAVR for low-flow, low-gradient aortic stenosis: Prognostic impact of aortic valve calcification.
    Am Heart J. 2020;225:138-148.
    PubMed     Abstract available
    
    
    
29. DAMLUJI AA, Rodriguez G, Noel T, Davis L, et al
    Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement.
    Am Heart J. 2020;224:171-181.
    PubMed     Abstract available
    
    
    March 2020
30. VESELKA J
    Consequences of impressive myectomy results in a Center of Excellence: The paradox of evidence-based medicine era.
    Am Heart J. 2020;221:157-158.
    PubMed    
    
    
    
31. GESKE JB, Driver CN, Yogeswaran V, Ommen SR, et al
    Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy.
    Am Heart J. 2020;221:159-164.
    PubMed     Abstract available
    
    
    February 2020
32. PINEDA AM, Rymer J, Wang A, Banks AZ, et al
    Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.
    Am Heart J. 2020;224:105-112.
    PubMed     Abstract available
    
    
    
33. ROZENBAUM Z, Finkelstein A, Zhitomirsky S, Topilsky Y, et al
    Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Am Heart J. 2020;220:184-191.
    PubMed     Abstract available
    
    
    January 2020
34. KALBACHER D, Tigges E, Boekstegers P, Puls M, et al
    Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.
    Am Heart J. 2020;222:73-82.
    PubMed     Abstract available
    
    
    
35. LU DY, Ventoulis I, Liu H, Kudchadkar SM, et al
    Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
    Am Heart J. 2020;219:58-69.
    PubMed     Abstract available
    
    
    December 2019
36. MEGALY M, Gossl M, Sorajja P, Anzia LE, et al
    Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement.
    Am Heart J. 2019;218:128-132.
    PubMed     Abstract available
    
    
    October 2019
37. VENN RA, Ning M, Vlahakes GJ, Wasfy JH, et al
    Surgical timing in infective endocarditis complicated by intracranial hemorrhage.
    Am Heart J. 2019;216:102-112.
    PubMed     Abstract available
    
    
    August 2019
38. PAPOUTSIDAKIS N, Heitner S, Ingles J, Semsarian C, et al
    Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude.
    Am Heart J. 2019;214:28-35.
    PubMed     Abstract available
    
    
    March 2019
39. PRIROMPRINTR B, Silka MJ, Rhodes J, Batra AS, et al
    A prospective 5-year study of exercise performance following Melody valve implant.
    Am Heart J. 2019;209:47-53.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: